The transcriptional levels of HERV-K (HML-2) gag, pol, and env in lung cancers were significantly upregulated compared with those in healthy controls (p < 0.0001, p < 0.05, and p < 0.01, respectively, Figures 3A–C). This evidence concerns the gene ERVW-1 and lung carcinoma.